AstraZeneca digs deeper into cancer with Innate stake

AstraZeneca is plowing deeper into cancer immunotherapy through a wide-ranging deal with Innate Pharma, which includes the British group buying a 9.8 percent stake in the French biotech company.

from Reuters: Health https://ift.tt/2CytJuI
via IFTTT

• Tweet
• Share
• Share
• Share
• Share